Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | C1orf43 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
mRNA | CSRNP3 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
mRNA | ZNF568 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
mRNA | ETV6 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
mRNA | SIPA1L2 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
mRNA | DYM | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
mRNA | SLC23A2 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
mRNA | CELF2 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-06 |
mRNA | GABRB3 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-06 |
mRNA | TULP4 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |